South Korea Insulin Delivery Market Outlook to 2022

  • ID: 4031179
  • Report
  • Region: South Korea
  • 40 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Diamesco Co Ltd
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Novo Nordisk A/S
  • Sanofi
  • MORE
South Korea Insulin Delivery Market Outlook to 2022

Summary

The author's new report, "South Korea Insulin Delivery Market Outlook to 2022", provides key market data on the South Korea Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Insulin Delivery market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the South Korea Insulin Delivery market.
- Key players covered include Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Diamesco Co Ltd
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Novo Nordisk A/S
  • Sanofi
  • MORE
1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Insulin Delivery Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Insulin Delivery Market, South Korea

3.1 Insulin Delivery Market, South Korea, Revenue ($m), 2008-2015

3.2 Insulin Delivery Market, South Korea, Revenue ($m), 2015-2022

3.2.1 Insulin Pens Market, South Korea, Revenue ($m), by Segment, 2008-2015

3.2.2 Insulin Pumps Market, South Korea, Revenue ($m), by Segment, 2008-2015

3.2.3 Insulin Pens Market, South Korea, Revenue ($m), by Segment, 2015-2022

3.2.4 Insulin Pumps Market, South Korea, Revenue ($m), by Segment, 2015-2022

3.3 Insulin Delivery Market, South Korea, Volume (Units), 2008-2015

3.4 Insulin Delivery Market, South Korea, Volume (Units), 2015-2022

3.4.1 Insulin Pens Market, South Korea, Volume (Units), by Segment, 2008-2015

3.4.2 Insulin Pumps Market, South Korea, Volume (Units), by Segment, 2008-2015

3.4.3 Insulin Pens Market, South Korea, Volume (Units), by Segment, 2015-2022

3.4.4 Insulin Pumps Market, South Korea, Volume (Units), by Segment, 2015-2022

3.5 Insulin Delivery Market, South Korea, Average Price ($), 2008-2022

3.6 Insulin Delivery Market, South Korea, Distribution Share by Revenue ($m), 2014-2015

3.7 Insulin Delivery Market, South Korea, Company Share by Revenue ($m), 2015

4 Overview of Key Companies in South Korea, Insulin Delivery Market

4.1 Eli Lilly and Company

4.1.1 Company Overview

4.2 Sanofi

4.2.1 Company Overview

4.3 Becton Dickinson and Co

4.3.1 Company Overview

4.4 Novo Nordisk A/S

4.4.1 Company Overview

4.5 F. Hoffmann-La Roche Ltd

4.5.1 Company Overview

4.6 Diamesco Co Ltd

4.6.1 Company Overview

5 Insulin Delivery Market Pipeline Products

6 Financial Deals Landscape

6.1 Partnerships

6.1.1 Metabolon Enters into Licensing Agreement with Synlab

7 Appendix

7.1 Research Methodology

7.1.1 Coverage

7.1.2 Secondary Research

7.1.3 Primary Research

7.1.4 Company Share Analysis

7.1.5 Distribution Share Analysis

7.1.6 Benchmarking

7.2 Consulting

7.3 Contact Us

7.4 Disclaimer

1.1 List of Tables

Table 1: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015

Table 2: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 3: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015

Table 4: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015

Table 5: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 6: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022

Table 7: Insulin Delivery Market, South Korea, Volume (Units), Historic, 2008-2015

Table 8: Insulin Delivery Market, South Korea, Volume (Units), Forecast, 2015-2022

Table 9: Insulin Pens Market, South Korea, Volume (Units), Historic, 2008-2015

Table 10: Insulin Pumps Market, South Korea, Volume (Units), Historic, 2008-2015

Table 11: Insulin Pens Market, South Korea, Volume (Units), Forecast, 2015-2022

Table 12: Insulin Pumps Market, South Korea, Volume (Units), Forecast, 2015-2022

Table 13: Insulin Delivery Market, South Korea, Average Price ($) Historic, 2008-2022

Table 14: Insulin Delivery Market, South Korea, Average Price ($), Forecast, 2015-2022

Table 15: Insulin Delivery Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2014-2015

Table 16: Insulin Delivery Market, South Korea, Company Share by Revenue ($m), USD Constant, 2015

Table 17: Insulin Delivery Market Pipeline Products

Table 18: Metabolon Enters into Licensing Agreement with Synlab

1.2 List of Figures

Figure 1: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 2: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 3: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 4: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015

Figure 5: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 6: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022

Figure 7: Insulin Delivery Market, South Korea, Volume (Units), Historic, 2008-2015

Figure 8: Insulin Delivery Market, South Korea, Volume (Units), Forecast, 2015-2022

Figure 9: Insulin Pens Market, South Korea, Volume (Units), Historic, 2008-2015

Figure 10: Insulin Pumps Market, South Korea, Volume (Units), Historic, 2008-2015

Figure 11: Insulin Pens Market, South Korea, Volume (Units), Forecast, 2015-2022

Figure 12: Insulin Pumps Market, South Korea, Volume (Units), Forecast, 2015-2022

Figure 13: Insulin Delivery Market, South Korea, Company Share (%) 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Eli Lilly and Company
  • Sanofi
  • Becton Dickinson and Co
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche Ltd
  • Diamesco Co Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll